PL378221A1 - Tienopirydazynony i ich zastosowanie w modulacji choroby autoimmunologicznej - Google Patents

Tienopirydazynony i ich zastosowanie w modulacji choroby autoimmunologicznej

Info

Publication number: PL378221A1
Authority: PL; Poland
Prior art keywords: thienopyridazinones; modulation; autoimmune disease; autoimmune; disease
Prior art date: 2003-01-17

Application number

PL378221A

Other languages

English (en)

Inventor

Simon David Guile

Anthony Howard Ingall

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-17

Filing date

2004-01-15

Publication date

2006-03-20

2003-01-17 Priority claimed from SE0300118A external-priority patent/SE0300118D0/xx

2003-01-17 Priority claimed from SE0300117A external-priority patent/SE0300117D0/xx

2004-01-15 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-03-20 Publication of PL378221A1 publication Critical patent/PL378221A1/pl

Links

208000023275 Autoimmune disease Diseases 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Neurology (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Oncology (AREA)
Virology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Ophthalmology & Optometry (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Obesity (AREA)
Emergency Medicine (AREA)

PL378221A 2003-01-17 2004-01-15 Tienopirydazynony i ich zastosowanie w modulacji choroby autoimmunologicznej PL378221A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0300118A SE0300118D0 (sv)	2003-01-17	2003-01-17	Novel Compounds
SE0300117A SE0300117D0 (sv)	2003-01-17	2003-01-17	Novel Compounds

Publications (1)

Publication Number	Publication Date
PL378221A1 true PL378221A1 (pl)	2006-03-20

Family

ID=32775326

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL378221A PL378221A1 (pl)	2003-01-17	2004-01-15	Tienopirydazynony i ich zastosowanie w modulacji choroby autoimmunologicznej

Country Status (15)

Country	Link
US (2)	US7393854B2 (pl)
EP (1)	EP1587811A1 (pl)
JP (1)	JP2006515880A (pl)
KR (1)	KR20050092761A (pl)
AU (1)	AU2004206011B2 (pl)
BR (1)	BRPI0406782A (pl)
CA (1)	CA2512136A1 (pl)
IL (1)	IL169369A0 (pl)
IS (1)	IS7962A (pl)
MX (1)	MXPA05007495A (pl)
NO (1)	NO20053825L (pl)
NZ (1)	NZ541218A (pl)
PL (1)	PL378221A1 (pl)
RU (1)	RU2332420C2 (pl)
WO (1)	WO2004065395A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0117583D0 (en) *	2001-07-19	2001-09-12	Astrazeneca Ab	Novel compounds
GB0118479D0 (en) *	2001-07-28	2001-09-19	Astrazeneca Ab	Novel compounds
SE0300119D0 (sv)	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
US7393854B2 (en) *	2003-01-17	2008-07-01	Astrazeneca Ab	Thienopyrimidinedinones and their use in modulation of autoimmune disease
SE0300120D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
SG11201602566XA (en) *	2013-10-21	2016-05-30	Genosco	Substituted pyrimidine compounds and their use as syk inhibitors
UY36586A (es) *	2015-03-26	2016-10-31	Bayer Pharma AG	Heterociclilmetiltienouracilos y uso de los mismos

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9702001D0 (sv) *	1997-05-28	1997-05-28	Astra Pharma Prod	Novel compounds
US6984644B2 (en) *	1997-05-28	2006-01-10	Astrazeneca Ab	Treatment of skin disorders using thieno[2,3-D]pyrimidinediones
US6469014B1 (en) *	1997-05-28	2002-10-22	Astrazeneca Ab	Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy
IL136499A0 (en)	1997-12-05	2001-06-14	Astrazeneca Uk Ltd Astrazeneca	Pyrrolo-, thieno-, furano- and pyrazolo-[3,4,d] pypyrrolo-, thieno-, furano- and pyrazolo-[3,4,d] pyridazinone compounds, process for their preparatioridaziones compounds, process for their preparation, pharmaceutical compositions containing them, a n, pharmaceutical compositions containing them, a process for prepating the pharmaceutical compositiprocess for preparing the pharmaceutical compositions, and use thereof ons, and use thereof
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
US6233320B1 (en) *	1998-06-22	2001-05-15	Lucent Technologies Inc.	Method and apparatus for recording and playing back a conversation using a digital wireless phone
US6300334B1 (en) *	1998-08-28	2001-10-09	Astrazeneca Ab	Thieno[2,3-d]pyrimidine-2,4-diones
DE60104677T2 (de) *	2000-05-04	2005-07-28	Astrazeneca Ab	THIENO[2,3-d]PYRIMIDINDIONE UND IHRE VERWENDUNG ALS PHARMAZEUTISCHE MITTEL
GB0117583D0 (en)	2001-07-19	2001-09-12	Astrazeneca Ab	Novel compounds
GB0118479D0 (en) *	2001-07-28	2001-09-19	Astrazeneca Ab	Novel compounds
SE0300119D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
US7393854B2 (en) *	2003-01-17	2008-07-01	Astrazeneca Ab	Thienopyrimidinedinones and their use in modulation of autoimmune disease
SE0300120D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds

2004
- 2004-01-15 US US10/542,457 patent/US7393854B2/en not_active Expired - Fee Related
- 2004-01-15 KR KR1020057013127A patent/KR20050092761A/ko not_active Ceased
- 2004-01-15 AU AU2004206011A patent/AU2004206011B2/en not_active Ceased
- 2004-01-15 JP JP2006500751A patent/JP2006515880A/ja active Pending
- 2004-01-15 EP EP04702470A patent/EP1587811A1/en not_active Withdrawn
- 2004-01-15 PL PL378221A patent/PL378221A1/pl not_active Application Discontinuation
- 2004-01-15 BR BR0406782-7A patent/BRPI0406782A/pt not_active IP Right Cessation
- 2004-01-15 RU RU2005121492/04A patent/RU2332420C2/ru not_active IP Right Cessation
- 2004-01-15 CA CA002512136A patent/CA2512136A1/en not_active Abandoned
- 2004-01-15 MX MXPA05007495A patent/MXPA05007495A/es active IP Right Grant
- 2004-01-15 WO PCT/SE2004/000053 patent/WO2004065395A1/en not_active Ceased
- 2004-01-15 NZ NZ541218A patent/NZ541218A/en unknown
2005
- 2005-06-23 IL IL169369A patent/IL169369A0/en unknown
- 2005-07-27 IS IS7962A patent/IS7962A/is unknown
- 2005-08-15 NO NO20053825A patent/NO20053825L/no not_active Application Discontinuation
2008
- 2008-05-21 US US12/124,319 patent/US20080221131A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2006515880A (ja)	2006-06-08
RU2332420C2 (ru)	2008-08-27
IS7962A (is)	2005-07-27
US20060135539A1 (en)	2006-06-22
RU2005121492A (ru)	2006-02-10
WO2004065395A1 (en)	2004-08-05
EP1587811A1 (en)	2005-10-26
US7393854B2 (en)	2008-07-01
BRPI0406782A (pt)	2006-01-17
AU2004206011B2 (en)	2007-07-12
MXPA05007495A (es)	2005-09-21
IL169369A0 (en)	2007-07-04
AU2004206011A1 (en)	2004-08-05
CA2512136A1 (en)	2004-08-05
NO20053825L (no)	2005-10-17
US20080221131A1 (en)	2008-09-11
NZ541218A (en)	2008-05-30
KR20050092761A (ko)	2005-09-22
NO20053825D0 (no)	2005-08-15

Legal Events

Date	Code	Title	Description
2012-03-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL159785A0 (en)	2004-06-20	Thienopyrimidinediones and their use in the modulation of autoimmune disease
PT2702871T (pt)	2019-02-01	Biotecido de colagénio e sua utilização
GB0302098D0 (en)	2003-02-26	Improvements in and relating to surgical clips
PL1678194T3 (pl)	2014-01-31	Modulowanie syntezy i degradacji hialuronianu w leczeniu choroby
ZA200600387B (en)	2009-06-24	Hydrolytically-resistant bornon-containing therapeutics and methods of use
EP1549614A4 (en)	2008-04-16	VASCULATORY AGENTS AND METHODS FOR THEIR APPLICATION
AU2003207698A8 (en)	2005-10-20	Needle-suture combinations and methods of use
IL172316A0 (en)	2011-08-01	Novel compounds and their use in therapy
TWI316092B (en)	2009-10-21	Alloy and its use
AU2003215257A8 (en)	2003-09-09	Modified defensins and their use
AU2003219093A8 (en)	2003-10-08	Anti-hpv-16 e7 antibodies and their use
IL169369A0 (en)	2007-07-04	Thienopyridazinones and their use in modulation of autoimmune disease
SG110107A1 (en)	2005-04-28	Compound and use in treatment
GB0318546D0 (en)	2003-09-10	Quinoxalinones and their use
SI1639013T1 (sl)	2013-01-31	Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji
AU2003209459A8 (en)	2003-09-16	Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
GB0320834D0 (en)	2003-10-08	Dispersion and use thereof
HK1081947A (en)	2006-05-26	Thienopyridazinones and their use in modulation of autoimmune disease
EP1587829A4 (en)	2006-05-31	HUMAN PROTOONKOGEN AND THE CODED PROTEIN
GB0207596D0 (en)	2002-05-15	Improvements in or relating to patient support structures and their use
GB0219103D0 (en)	2002-09-25	Medical kit and use thereof
GB0312822D0 (en)	2003-07-09	Triazolo-pyrimidine compounds and their use in medicine
GB0319028D0 (en)	2003-09-17	Pyrazolo-pyrimidine compounds and their use in medicine
GB0312296D0 (en)	2003-07-02	Pyrazolo-pyrimidine compounds and their use in medicine
AU2002360082A1 (en)	2004-07-22	Human autoantigens and use thereof